Inventor
HUI-LING WANG
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
G01CMeasuring distances, levels or bearings4%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes4%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
12,583,854KRAS G12C inhibitors and methods of using the same202612,440,491KRAS G12C inhibitors and methods of using the same202512,083,121Substituted piperazines as KRAS G12C inhibitors202411,993,597Inhibitors of KRAS G12C and methods of using the same202411,766,436KRAS G12C inhibitors and methods of using the same202311,306,087Inhibitors of KRAS G12C and methods of using the same202211,285,135KRAS G12C inhibitors and methods of using the same202211,285,156Substituted piperazines as KRAS G12C inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to AMGEN INC (8)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 8 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2026 |